Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

GRN163L peptide × Plasma cell × 90 days × Clear all

Sponsor

Cancer Type

Other hematologic neoplasm 1

Interventions

Dexamethasone 128 Lenalidomide 77 daratumumab 70 Bortezomib 60 Cyclophosphamide 48 carfilzomib 44 Calcium Dobesilate 43 pomalidomide 42 Specimen Handling 34 fludarabine 30 Biopsy 30 Magnetic Resonance Spectroscopy 25 talquetamab 19 isatuximab 19 dexamethasone acetate 19 dexamethasone 21-phosphate 19 auricularum 19 iberdomide 17 fludarabine phosphate 15 belantamab mafodotin 13 selinexor 12 X-Rays 11 elotuzumab 10 Melphalan 10 tocilizumab 9 venetoclax 7 trametinib 7 Whole-Body Irradiation 7 Nivolumab 7 ixazomib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡